- CVD_REAL: The Real Benefit of Gliglozins for the Treatment of Type 2 Diabetes in Common Clinical Practice2018 | Faculty of Medicine in Hradec Králové
- Studie CVD Real Nordic2017 | First Faculty of Medicine
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study2018 | First Faculty of Medicine
- Komentář ke studii CVD-REAL2017 | Second Faculty of Medicine
